Skip to main content
19 Dec | 2022

We found that a genetic predisposition to longer telomeres could have a protective effect against Alzheimer's

The investigations have been led by the Barcelonaβeta Brain Research Center (BBRC) and have included participants without cognitive alterations from the ALFA Study, with the support of the ”la Caixa” Foundation

05 Dec | 2022

Dr. Josep Maria Argimon, appointed Director of the Scientific Infrastructure of the Barcelonaβeta Brain Research Center

The Research Center of the Pasqual Maragall Foundation incorporates Dr. Argimon to lead the development and management of its research infrastructures, studies and cohorts.

30 Nov | 2022

A new research drug against Alzheimer's confirms its positive results during CTAD

The results, published in The New England Journal of Medicine, confirm that lecanemab slows cognitive decline by 27% in patients in the early stages of Alzheimer's disease.

29 Nov | 2022

Dr. Juan Domingo Gispert presents the results of AMYPAD at an FDA seminar

The BBRC researcher and group leader gave a presentation on sources of variability in quantitative amyloid PET metrics

16 Nov | 2022

The validity of nine biomarkers for diagnosing Alzheimer's disease in daily clinical practice has been determined

A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.

03 Nov | 2022

New data indicate an association between poor sleep quality and an increased risk of developing Alzheimer's

The research, within the European project EPAD, is headed by the Barcelonaβeta Brain Research Center (BBRC), a research center of the Pasqual Maragall Foundation, together with the University of Bristol.

28 Oct | 2022

Raffaele Cacciaglia receives the Ramón y Cajal 2021 grant

The award is a recognition of the trajectory of the researcher, recipient in addition to a Knowledge Generation Project 2021

18 Oct | 2022

Relationship between symptoms of anxiety and depression during confinement and subjective cognitive decline found

In the research, led by the BBRC, 250 people without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation, have participated.

10 Oct | 2022

The AMYPAD project is successfully completed

The consortium has officially ended its formal operation after six years of joint efforts and collaboration.